IMGN - ImmunoGen GAAP EPS of $0.10 beats by $0.06 revenue of $113.4M beats by $8.19M
2023-11-02 06:31:36 ET
More on ImmunoGen
- Analyzing The Acquisition Potential Of ImmunoGen
- ImmunoGen: Takeda Swoops For Slice Of Elahere - Adding To Valuation Uncertainty?
- ImmunoGen Stock Falls, Elahere Growth Contrasts (Rating Upgrade)
- ImmunoGen Q3 2023 Earnings Preview
- ImmunoGen's ovarian cancer medication accepted for EU review
For further details see:
ImmunoGen GAAP EPS of $0.10 beats by $0.06, revenue of $113.4M beats by $8.19M